Trials / Completed
CompletedNCT05586880
Study to Evaluate Efficacy of EnXtra on Accuracy & Reaction Time, Perceived Alertness & Digital Fatigue for Video Gamers
A Randomized, Placebo-controlled, Double-blind Crossover Study to Evaluate Efficacy of EnXtra on Accuracy & Reaction Time, Perceived Alertness & Digital Fatigue for Video Gamers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
In the present study, Sponsor aim to evaluate the effects of EnXtra® as to improve Accuracy \& Reaction Time, Perceived Alertness \& Digital Fatigue for Video Gamers. A Randomized, Placebo-controlled, Double-blind Crossover Study of 60 randomized cross over for total study duration of approximately 25 days with 5 days of treatment period for each arm and 5-7 days wash out period between both arms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Experimental: EnXtra 300 mg/ capsule | One capsule to be taken 3±0.5 hours prior to second gaming session on Day 1 followed by 1 capsule daily after breakfast for 5 days |
| OTHER | Microcrystalline cellulose (MCC) 300mg | One capsule to be taken 3±0.5 hours prior to second gaming session on Day 1 followed by 1 capsule daily after breakfast for 5 days |
Timeline
- Start date
- 2022-10-10
- Primary completion
- 2023-01-28
- Completion
- 2023-01-28
- First posted
- 2022-10-19
- Last updated
- 2023-03-24
Locations
2 sites across 1 country: India
Source: ClinicalTrials.gov record NCT05586880. Inclusion in this directory is not an endorsement.